Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
1.
J Dermatol ; 51(6): 869-872, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38214494

ABSTRACT

A 73-year-old man with diabetes mellitus was referred to our department for ultraviolet treatment for erythematous skin lesions with itching. On dipeptidyl peptidase-4 inhibitor (DPP-4i) sitagliptin (Januvia®) for diabetes mellitus, the erythematous skin lesions appeared and spread to the whole body. At the initial visit, erythema multiforme-like skin lesions with crusts were observed on the trunk and extremities, and the patient was suspected to have drug eruption. Histopathology demonstrated eosinophilic infiltration in the superficial dermis and inflammatory cell infiltration in the epidermis. Sitagliptin was discontinued, and erythematous lesions improved with oral prednisolone. Thereafter the patient was treated with phototherapy and  betamethasone sodium phosphate infusion for residual prurigo. However, blistering skin lesions appeared 5 months later. Histopathological findings were subepidermal blisters with eosinophilic abscess, and bullous pemphigoid was suspected. CLEIAs for autoantibodies to desmoglein 1 (Dsg1), Dsg3 and BP180 were negative. Direct immunofluorescence showed linear depositions of immunoglobulin G (IgG) and C3 at the epidermal basement membrane zone, and indirect immunofluorescence detected IgG anti-epidermal basement membrane zone antibodies, reacting with the dermal side of 1M NaCl-split normal human skin. IgG antibodies reacted with 200 kDa laminin γ1 (p200) by immunoblotting using dermal extracts. These results indicated that this patient was diagnosed with anti-laminin γ1 (p200) pemphigoid developed after DPP-4i administration. Although reports of DPP-4i-related bullous pemphigoid have accumulated, cases of anti-laminin γ1 (p200) pemphigoid developed after DPP-4i administration are rarely reported.


Subject(s)
Autoantibodies , Dipeptidyl-Peptidase IV Inhibitors , Laminin , Pemphigoid, Bullous , Sitagliptin Phosphate , Humans , Male , Aged , Dipeptidyl-Peptidase IV Inhibitors/adverse effects , Pemphigoid, Bullous/chemically induced , Pemphigoid, Bullous/immunology , Pemphigoid, Bullous/diagnosis , Pemphigoid, Bullous/pathology , Pemphigoid, Bullous/drug therapy , Laminin/immunology , Autoantibodies/immunology , Autoantibodies/blood , Sitagliptin Phosphate/adverse effects , Skin/pathology , Skin/drug effects , Skin/immunology , Drug Eruptions/etiology , Drug Eruptions/pathology , Drug Eruptions/diagnosis , Drug Eruptions/immunology , Prednisolone/therapeutic use , Prednisolone/administration & dosage , Diabetes Mellitus, Type 2/drug therapy , Diabetes Mellitus, Type 2/immunology , Diabetes Mellitus, Type 2/complications
2.
Biosci Biotechnol Biochem ; 85(12): 2404-2409, 2021 Nov 24.
Article in English | MEDLINE | ID: mdl-34562094

ABSTRACT

Tropane alkaloids, including clinically important hyoscyamine and scopolamine, are produced in the roots of medicinal plant species, such as Atropa belladonna, from the Solanaceae family. Recent molecular and genomic approaches have advanced our understanding of the metabolic enzymes involved in tropane alkaloid biosynthesis. A noncanonical type III polyketide synthase, pyrrolidine ketide synthase (PYKS) catalyzes a two-step decarboxylative reaction, which involves imine-ketide condensation indispensable to tropane skeleton construction. In this study, we generated pyks mutant A. belladonna hairy roots via CRISPR/Cas9-mediated genome editing and analyzed the metabolic consequences of the loss of PYKS activity on tropane alkaloids, providing insights into a crucial role of the scaffold-forming reaction in the biosynthetic pathway.


Subject(s)
Atropa belladonna
3.
Acta Derm Venereol ; 98(9): 855-861, 2018 Oct 10.
Article in English | MEDLINE | ID: mdl-29972224

ABSTRACT

Skin thermal changes modulate itch sensitivity. However, the mechanisms of this modulation are still unclear. Using mouse models of acute and chronic itch, we investigated whether local innocuous thermal stimulation of the skin alters itch sensitivity and if blockade of thermosensitive transient receptor potential (TRP) channels can reduce these changes. Localized thermal changes were achieved by placing a thermal probe in contact with the back skin for 30 s. Warming the skin significantly increased serotonin-evoked scratching and spontaneous scratching in the ovalbumin model of atopic dermatitis but decreased histamine-evoked scratching. These changes were blocked by a TRPV4 antagonist. Cooling the skin significantly increased serotonin-evoked scratching but reduced histamine-evoked scratching. The increase in serotonin-evoked scratching, but not the reduction of histamine-evoked scratching, was blocked by TRPM8 antagonism. Chloroquine-evoked scratching was unaffected by either warming or cooling. Our data indicate that different itch signaling pathways are differentially modulated by skin thermal changes.


Subject(s)
Dermatitis, Atopic/prevention & control , Hyperthermia, Induced , Hypothermia, Induced , Pruritus/prevention & control , Skin/blood supply , Animals , Antipruritics/pharmacology , Body Temperature Regulation , Dermatitis, Atopic/chemically induced , Dermatitis, Atopic/metabolism , Dermatitis, Atopic/physiopathology , Disease Models, Animal , Histamine , Male , Mice, Inbred C57BL , Ovalbumin , Pruritus/chemically induced , Pruritus/metabolism , Pruritus/physiopathology , Regional Blood Flow , Serotonin , Skin/drug effects , Skin/metabolism , TRPM Cation Channels/antagonists & inhibitors , TRPM Cation Channels/metabolism , TRPV Cation Channels/antagonists & inhibitors , TRPV Cation Channels/metabolism
4.
J Dermatol ; 45(4): 479-482, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29215146

ABSTRACT

Thymoma-associated graft-versus-host disease (GVHD)-like disease is a rare paraneoplastic disease seen in patients with thymoma. Here, we describe the first case of thymoma-associated GVHD-like disease localized to the skin that was successfully improved by a combination of systemic corticosteroids and whole-body narrowband ultraviolet (UV)-B phototherapy. The patient had developed toxic epidermal necrolysis-like erosive skin lesions over the whole body. Although systemic corticosteroids were effective up to a point, we were unable to begin the steroid taper. The addition of systemic narrowband UV-B phototherapy improved the skin manifestation of this disease, allowing corticosteroids to be reduced to a third of the original dose. Histopathologically, it was confirmed that the proportion of Foxp3-positive lymphocytes in the skin increased after narrowband UV-B irradiation. We propose that whole-body narrowband UV-B phototherapy is a good therapeutic option for the skin manifestation of thymoma-associated GVHD-like disease.


Subject(s)
Graft vs Host Disease/radiotherapy , Skin Diseases/radiotherapy , Thymoma/complications , Thymus Neoplasms/complications , Ultraviolet Therapy/methods , Whole-Body Irradiation/methods , Biopsy , Female , Graft vs Host Disease/etiology , Graft vs Host Disease/pathology , Humans , Middle Aged , Skin/pathology , Skin/radiation effects , Skin Diseases/etiology , Treatment Outcome
5.
J Vasc Surg ; 66(4): 1285-1289, 2017 10.
Article in English | MEDLINE | ID: mdl-28705593

ABSTRACT

A total of 576 patients underwent endovascular aneurysm repair using main body devices for treatment of abdominal aortic aneurysms or iliac artery aneurysms. During follow-up, type IIIb endoleaks caused by fabric tear occurred in six patients (1.0% [6/576]). The device used was Zenith (Cook Medical, Bloomington, Ind) in five cases and Talent (Medtronic, Santa Rosa, Calif) in one case. All endoleaks were close to the flow divider of the main body devices. The distance between the lower renal artery and the top end of the contralateral leg was 53 ± 14 mm. Bell-bottom-shaped Excluder (W. L. Gore & Associates, Flagstaff, Ariz) legs were placed parallel from the top of the main body device through both legs to treat these endoleaks. In two patients, coil embolization was required to treat gutter endoleaks. Postoperative computed tomography showed the obliteration of type IIIb endoleaks in all patients. Our technique may be an acceptable method for treatment of type IIIb endoleaks, especially when they occur near the flow divider.


Subject(s)
Aortic Aneurysm, Abdominal/surgery , Blood Vessel Prosthesis Implantation/instrumentation , Blood Vessel Prosthesis , Endoleak/surgery , Endovascular Procedures/instrumentation , Iliac Aneurysm/surgery , Prosthesis Failure , Aged , Aged, 80 and over , Aortic Aneurysm, Abdominal/diagnostic imaging , Aortography/methods , Blood Vessel Prosthesis Implantation/adverse effects , Computed Tomography Angiography , Echocardiography, Doppler, Color , Embolization, Therapeutic , Endoleak/diagnostic imaging , Endoleak/etiology , Endovascular Procedures/adverse effects , Humans , Iliac Aneurysm/diagnostic imaging , Male , Prosthesis Design , Treatment Outcome
6.
PLoS One ; 11(7): e0159661, 2016.
Article in English | MEDLINE | ID: mdl-27441843

ABSTRACT

Onychomycosis is difficult to treat topically due to the deep location of the infection under the densely keratinized nail plate. In order to obtain an in vitro index that is relevant to the clinical efficacy of topical anti-onychomycosis drugs, we profiled five topical drugs: amorolfine, ciclopirox, efinaconazole, luliconazole, and terbinafine, for their nail permeabilities, keratin affinities, and anti-dermatophytic activities in the presence of keratin. Efinaconazole and ciclopirox permeated full-thickness human nails more deeply than luliconazole. Amorolfine and terbinafine did not show any detectable permeation. The free-drug concentration of efinaconazole in a 5% human nail keratin suspension was 24.9%, which was significantly higher than those of the other drugs (1.1-3.9%). Additionally, efinaconazole was released from human nail keratin at a greater proportion than the other drugs. The MICs of the five drugs for Trichophyton rubrum were determined at various concentrations of keratin (0-20%) in RPMI 1640 medium. The MICs of ciclopirox were not affected by keratin, whereas those of efinaconazole were slightly increased and those of luliconazole and terbinafine were markedly increased in the presence of 20% keratin. Efficacy coefficients were calculated using the nail permeation flux and MIC in media without or with keratin. Efinaconazole showed the highest efficacy coefficient, which was determined using MIC in media with keratin. The order of efficacy coefficients determined using MIC in keratin-containing media rather than keratin-free media was consistent with that of complete cure rates in previously reported clinical trials. The present study revealed that efficacy coefficients determined using MIC in keratin-containing media are useful for predicting the clinical efficacies of topical drugs. In order to be more effective, topical drugs have to possess higher efficacy coefficients.


Subject(s)
Antifungal Agents/administration & dosage , Antifungal Agents/therapeutic use , Culture Media/chemistry , Keratins/chemistry , Nails/microbiology , Onychomycosis/drug therapy , Onychomycosis/microbiology , Administration, Topical , Antifungal Agents/pharmacology , Humans , Microbial Sensitivity Tests , Nails/drug effects , Permeability/drug effects , Treatment Outcome , Trichophyton/drug effects
7.
Dermatol Ther ; 27(4): 233-5, 2014.
Article in English | MEDLINE | ID: mdl-24962025

ABSTRACT

Hailey-Hailey disease (HHD) is a rare autosomal dominant disorder characterized by development of recurrent blisters, erosions, and crustations in the intertriginous areas. The treatment of HHD is often challenging, and various methods have been tried. We report here a case of a 45-year-old woman with a generalized form of HHD that was dramatically improved and well controlled by narrow-band ultraviolet B phototherapy.


Subject(s)
Calcium-Transporting ATPases/genetics , Pemphigus, Benign Familial/radiotherapy , Ultraviolet Therapy/methods , Female , Humans , Middle Aged , Mutation/genetics , Pemphigus, Benign Familial/genetics , RNA Splice Sites/genetics , Treatment Outcome
8.
J Matern Fetal Neonatal Med ; 26(2): 197-200, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22928495

ABSTRACT

AIM: Based on a maternal observation, we aimed to evaluate the treatment effectiveness of guaiazulene (GA) containing local pomade in the high-risk neonates with recalcitrant diaper dermatitis (RDD). METHODS: We included 30 NICU patients of RDD, with level II-III aged between 22 and 67 days. Study group patients (n = 20) were treated with GA containing local pomade (0.05 g/100 g). Control group consisted of patients who had extended antifungal treatment. A visual scale was used to assess the response to treatment at the end of a week. Scoring was done at the beginning of the treatment, on the first, third and seventh days. RESULTS: Statistically significant differences in visual scores were determined between the two groups at the initial and following days of the treatment. In study group, improvements at the first and third days of the treatment were better than those of control group. Additionally, complete recovery rate in study group was better than that in controls. CONCLUSION: Having beneficial but no adverse effects, GA containing local pomade provided rapid recovery in risky neonates with RDD, who required rapid improvement.


Subject(s)
Azulenes/therapeutic use , Diaper Rash/drug therapy , Infant, Premature, Diseases/drug therapy , Intensive Care, Neonatal/methods , Sesquiterpenes/therapeutic use , Adult , Female , Humans , Infant , Infant, Newborn , Infant, Premature , Intensive Care Units, Neonatal , Male , Prospective Studies , Sesquiterpenes, Guaiane
9.
Gan To Kagaku Ryoho ; 39(12): 2234-6, 2012 Nov.
Article in Japanese | MEDLINE | ID: mdl-23268034

ABSTRACT

The patient was a 68-year-old man. Because sigmoid colon cancer and metastatic liver cancer was diagnosed in August 2009, an indwelling central venous port and sigmoid colon resection were implemented. The metastatic liver cancer was a huge tumor occupying the right hepatic lobe and caudate lobe. In consideration of the risk associated with the resection and the possibility of early recurrence, the postoperative chemotherapy was selected. He underwent 9 courses of bevacizumab (Bev)+FOLFOX. The tumor was observed to reduce but continued to occupy the right lobe and caudate lobe. At this point, the surgical treatment was selected because the tumor has been shrunk and there is no appearance of new metastases. In order to preserve residual liver function, he underwent percutaneous transhepatic portal embolization and then resection of the right lobe of the liver in February 2010. Although the Bev+FOLFOX treatment was started again after surgery as adjuvant chemotherapy, the metastatic liver cancer recurred in the remnant liver in August 2010. Because it was about 6 months from the first recurrence of liver resection, we decided to continue chemotherapy immediately without resection. However, the chemotherapy was insufficient to shrink the tumor, which increased because it was present at 3 locations in the liver. Therefore, partial hepatectomy at the 3 locations with positron-emission tomography was performed in February 2011. Since then, chemotherapy has not been performed in patients, and there is no recurrence as of March 2012. In the guideline for the treatment of liver metastasis of colorectal cancer, even though chemotherapy is currently developed, the surgical procedure is recommended for patients who are responsive to local therapy. If the cancer recur immediately after resection, it is difficult to decide whether to re-resect. We report the case in which the tumor-free status can be observed as a result of a combination of systemic chemotherapy and local therapy.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Liver Neoplasms/drug therapy , Sigmoid Neoplasms/drug therapy , Aged , Antibodies, Monoclonal, Humanized/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Bevacizumab , Combined Modality Therapy , Fluorouracil/administration & dosage , Hepatectomy , Humans , Leucovorin/administration & dosage , Liver Neoplasms/secondary , Liver Neoplasms/surgery , Male , Organoplatinum Compounds/administration & dosage , Sigmoid Neoplasms/pathology , Sigmoid Neoplasms/surgery , Time Factors
10.
Br J Nutr ; 107(11): 1566-9, 2012 Jun.
Article in English | MEDLINE | ID: mdl-21920061

ABSTRACT

Dietary fucoxanthin has been reported to exert several physiological functions, and fucoxanthinol is considered to be the primary active metabolite of fucoxanthin. However, there is no information about the pharmacokinetics of fucoxanthinol in human subjects. In the present study, eighteen human volunteers were orally administered kombu extract containing 31 mg fucoxanthin, and their peripheral blood was collected 5 min before and 0·5, 1, 2, 4, 8 and 24 h after the treatment. Plasma fucoxanthinol concentrations were measured by HPLC, and the pharmacokinetics of fucoxanthinol were as follows: maximum concentration, 44·2 nmol/l; time at maximum concentration, 4 h; terminal half-time, 7·0 h; area under the curve (AUC) for 1-24 h, 578·7 nmol/l × h; AUC(∞), 663·7 nmol/l × h. In addition to fucoxanthinol, we also attempted to detect amarouciaxanthin A, a hepatic metabolite of fucoxanthinol, using HPLC, but it was not present in the volunteers' plasma. On the other hand, a peak that was suspected to represent the cis-isomer of fucoxanthinol was found in the HPLC chromatogram. By comparing the present results with those of a previous study using mice, we found that the bioavailability and metabolism of fucoxanthinol differ between human subjects and mice.


Subject(s)
Dietary Supplements , Laminaria/chemistry , Xanthophylls/pharmacokinetics , beta Carotene/analogs & derivatives , Adult , Biological Availability , Biotransformation , Chromatography, High Pressure Liquid , Dietary Supplements/analysis , Female , Half-Life , Humans , Male , Middle Aged , Spectrophotometry , Xanthophylls/analysis , Xanthophylls/blood , Young Adult , beta Carotene/blood
11.
Am J Chin Med ; 39(4): 757-77, 2011.
Article in English | MEDLINE | ID: mdl-21721155

ABSTRACT

The commercial quality of Japanese Angelica radices -- Angelica acutiloba Kitagawa (Yamato-toki) and A. acutiloba Kitagawa var. sugiyama Hikino (Hokkai-toki) -- used in Kampo traditional herbal medicines, was studied by use of omics technologies. Complementary and alternative medical providers have observed in their clinical experience that differences in radix commercial quality reflect the differences in pharmacological responses; however, there has been little scientific examination of this phenomenon. The approach of omics, including metabolomics, transcriptomics, genomics, and informatics revealed a distinction between the radix-quality grades based on their metabolites, gene expression in human subjects, and plant genome sequences. Systems biology, constructing a network of omics data used to analyze this complex system, is expected to be a powerful tool for enhancing the study of radix quality and furthering a comprehensive understanding of all medicinal plants.


Subject(s)
Angelica , Drugs, Chinese Herbal/standards , Research Design , Systems Biology , Angelica/genetics , Animals , Genomics , Humans , Informatics , Medicine, Kampo , Metabolomics , Plant Roots , Plants, Medicinal , Transcriptome
12.
Article in English | MEDLINE | ID: mdl-20953432

ABSTRACT

To clarify the mechanism of the antiallergic activity of Agaricus blazei Murill extract (ABME), the present paper used an in vivo allergy model and an in vitro intestinal gut model. During OVA sensitization, the serum IgE levels decreased significantly in ABME group. Interleukin (IL)-4 and -5 produced from OVA-restimulated splenocytes was significantly decreased, and anti-CD3ε/CD28 antibody treatment also reduced IL-10, -4, and -5 production and increased IFN-γ production in ABME group. These results suggest that oral administration of ABME improves Th1/Th2 balance. Moreover, a coculture system constructed of Caco-2 cells and splenocytes from OT-II mice or RAW 264.7 cells indicated that the significant increases in IFN-γ production by ABME treatment. Therefore, it was concluded that the antiallergic activity of ABME was due to the activation of macrophages by epithelial cells and the promotion of the differentiation of naïve T cells into Th1 cells in the immune.

13.
Biosci Biotechnol Biochem ; 74(10): 2036-42, 2010.
Article in English | MEDLINE | ID: mdl-20944421

ABSTRACT

Artemisia princeps is a familiar plant as a food substance and medicinal herb. In this study, we evaluated the effects of an ethanol extract of A. princeps (APE) on glucose uptake in differentiated L6 muscle cells. Treatment with APE elevated deoxyglucose uptake, and translocation of the insulin-responsive glucose transporter (GLUT4) to the plasma membrane in L6 myotubes occurred. The PI3K inhibitor LY294002 attenuated glucose uptake induced by APE. Phosphorylation of the Ser(473) residue of Akt was not observed, but phosphorylation of PI3K, Akt (Thr(308)), and atypical PKC was. In addition, APE stimulated phosphorylation of AMP-activated protein kinase (AMPK) at a level similar to 5'-amino-5-imidazolecarboxamide-riboside (AICAR). These results indicate that APE stimulates glucose uptake by inducing GLUT4 translocation, which is in part mediated by combination of the PI3K-dependent atypical PKC pathway and AMPK pathways.


Subject(s)
Artemisia/chemistry , Glucose Transporter Type 4/metabolism , Glucose/metabolism , Muscle Cells/drug effects , Muscle Cells/metabolism , Plant Extracts/pharmacology , 3T3-L1 Cells , AMP-Activated Protein Kinases/metabolism , Adipocytes/cytology , Animals , Deoxyglucose/metabolism , Enzyme Inhibitors/pharmacology , Flavonoids/analysis , Mice , Muscle Cells/cytology , Muscle, Skeletal/cytology , Phenols/analysis , Phosphoinositide-3 Kinase Inhibitors , Phosphorylation/drug effects , Plant Extracts/chemistry , Polyphenols , Protein Transport/drug effects , Signal Transduction/drug effects
14.
J Nutr Sci Vitaminol (Tokyo) ; 53(4): 358-65, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17934243

ABSTRACT

Bioavailability of glabridin was elucidated to show that this compound is one of the active components in the traditional medicine licorice. Using a model of intestinal absorption, Caco-2 cell monolayer, incorporation of glabridin was examined. Glabridin was easily incorporated into the cells and released to the basolateral side at a permeability coefficient of 1.70+/-0.16 cm/s x 10(5). The released glabridin was the aglycone form and not a conjugated form. Then, 10 mg (30 micromol)/kg body weight of standard chemical glabridin and licorice flavonoid oil (LFO) containing 10 mg/kg body weight of glabridin were administered orally to rats, and the blood concentrations of glabridin was determined. Glabridin showed a maximum concentration 1 h after the dose, of 87 nmol/L for standard glabridin and 145 nmol/L for LFO glabridin, and decreased gradually over 24 h after the dose. The level of incorporation into the liver was about 0.43% of the dosed amount 2 h after the dose. These detected glabridins were in the aglycone form and not conjugated forms. The bioavailability was calculated to be AUC(inf) of 0.825 and 1.30 microM.h and elimination T(1/2 )of 8.2 and 8.5 h for standard glabridin and LFO, respectively. Adipocytokine levels were determined in the rats. The secreted amount of monocyte chemoattractant protein-1 was significantly lower in the glabridin group compared to control vehicle group. Thus, dietary glabridin was at least partly incorporated into the body in an unchanged form, though most dietary flavonoids are converted to non-active conjugate forms during intestinal absorption.


Subject(s)
Intestinal Mucosa/metabolism , Phenols/blood , Phenols/pharmacokinetics , Adiponectin/blood , Adiponectin/metabolism , Animals , Biological Availability , Caco-2 Cells , Cell Survival/physiology , Chemokine CCL2/blood , Glycyrrhiza/chemistry , Humans , Insulin/blood , Insulin/metabolism , Insulin Secretion , Intestinal Absorption , Isoflavones , Leptin/blood , Leptin/metabolism , Liver/metabolism , Male , Random Allocation , Rats , Rats, Sprague-Dawley , Tumor Necrosis Factor-alpha/blood , Tumor Necrosis Factor-alpha/metabolism
15.
Phytother Res ; 21(7): 668-70, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17444574

ABSTRACT

The present study compared the effects of six Chinese teas categorized by their production process: green, white, yellow, oolong, black and pu-erh teas, on carbon tetrachloride (CCl4)-induced liver injury. Wistar rats were given ad libitum the Chinese teas prepared according to the home-style methods for 1 week, and then intraperitoneally injected with CCl4 (1 mg/kg body weight) or olive oil as a vehicle. The yellow tea significantly ameliorated the increase in the activity of the alanine- and aspartate-aminotransferases in plasma. Thus, the drinking of yellow tea may contribute to protection against liver injury.


Subject(s)
Antioxidants/pharmacology , Beverages , Camellia sinensis , Chemical and Drug Induced Liver Injury/prevention & control , Liver/drug effects , Phytotherapy , Animals , Antioxidants/administration & dosage , Antioxidants/therapeutic use , Carbon Tetrachloride , Chemical and Drug Induced Liver Injury/etiology , Chemical and Drug Induced Liver Injury/pathology , Male , Plant Leaves , Rats , Rats, Wistar
16.
Biosci Biotechnol Biochem ; 70(1): 279-81, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16428850

ABSTRACT

Quercetin, rutin, the extract of white radish sprout rich in kaempferol glycosides, and their combination were intragastrically administered to Wistar rats to investigate the interactive metabolism of these flavonoids. The combined administration of these flavonoids changed the concentrations of the metabolites in plasma as compared with the concentrations after the administration of a single compound.


Subject(s)
Plant Extracts/blood , Plant Extracts/pharmacology , Quercetin/blood , Quercetin/pharmacology , Raphanus/chemistry , Rutin/blood , Rutin/pharmacology , Animals , Color , Glycosides/administration & dosage , Glycosides/blood , Glycosides/metabolism , Glycosides/pharmacology , Kaempferols/administration & dosage , Kaempferols/blood , Kaempferols/metabolism , Kaempferols/pharmacology , Male , Plant Extracts/administration & dosage , Plant Extracts/metabolism , Plant Shoots/chemistry , Quercetin/administration & dosage , Quercetin/metabolism , Rats , Rats, Wistar , Rutin/administration & dosage , Rutin/metabolism
17.
Biosci Biotechnol Biochem ; 68(11): 2353-9, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15564676

ABSTRACT

Obesity is a serious health problem, and its prevention is promoted through life style including diet and exercise. In this study, we investigated the suppressive effects of tea catechin on the differentiation of 3T3-L1 preadipocytes to adipocytes. (-)-Catechin 3-gallate (CG), (-)-epigallocatechin (EGC), (-)-epicatechin 3-gallate, and (-)-epigallocatechin 3-gallate at 5 muM suppressed intracellular lipid accumulation. The suppressive effects of CG and EGC were stronger than the others, and CG and EGC also suppressed the activity of glycerol-3-phosphate dehydrogenase as a differentiation marker. These catechins inhibited the expression of peroxisome proliferator-activated receptor (PPAR) gamma2 and CCAAT/enhancer-binding protein (C/EBP) alpha, both of which act as key transcription factors at an early stage of differentiation, followed by the expression of glucose transporter (GLUT) 4 at a later stage. In addition, the catechins did not affect the phosphorylation status of the insulin signal pathway. Thus, catechin suppressed adipocyte differentiation accompanied by the down-regulation of PPARgamma2, C/EBPalpha, and GLUT4. These results suggest that tea catechin prevents obesity through the suppression of adipocyte differentiation.


Subject(s)
Adipocytes/drug effects , CCAAT-Enhancer-Binding Protein-alpha/biosynthesis , Catechin/pharmacology , Down-Regulation/drug effects , PPAR gamma/biosynthesis , Tea/chemistry , 3T3 Cells , Animals , Azo Compounds , Blotting, Western , Cell Differentiation/drug effects , Dose-Response Relationship, Drug , Glucose Transporter Type 4 , Glyceraldehyde-3-Phosphate Dehydrogenases/metabolism , Immunoprecipitation , Insulin/physiology , Lipid Metabolism , Mice , Monosaccharide Transport Proteins/biosynthesis , Muscle Proteins/biosynthesis , Signal Transduction/drug effects , Transcription Factors
18.
Rinsho Shinkeigaku ; 44(7): 422-6, 2004 Jul.
Article in Japanese | MEDLINE | ID: mdl-15384702

ABSTRACT

We describe a patient with acute Wernicke encephalopathy (WE) in whom diffusion-weighted magnetic resonance imaging (DWI) were helpful for early diagnosis. A 66-year-old alcoholic man was admitted to our department because of recurrent mild drowsiness. Thiamine concentrations in blood were at the lower limit of normal. DWI demonstrated an abnormal signal intensity in the dorsal part of the midbrain, and high-dose thiamine therapy was started. These lesions disappeared on DWI after one month of follow-up, in association with clinical improvement. These findings suggest that DWI is useful for detecting WE at the early stage when high-dose thiamine treatment can improve the prognosis of WE.


Subject(s)
Magnetic Resonance Imaging/methods , Wernicke Encephalopathy/diagnosis , Acute Disease , Aged , Atrophy/pathology , Follow-Up Studies , Humans , Image Enhancement/methods , Male , Mesencephalon/pathology , Thiamine/administration & dosage , Wernicke Encephalopathy/drug therapy , Wernicke Encephalopathy/pathology
19.
Biofactors ; 22(1-4): 135-40, 2004.
Article in English | MEDLINE | ID: mdl-15630268

ABSTRACT

To investigate mechanisms of the anti-obesity actions of green tea in vivo, rats were given green tea instead of drinking water for 3 weeks. It was confirmed that green tea reduced adipose tissue weight without any change in body weight, other tissue weights, and food and water intakes. Green tea also significantly reduced the plasma levels of cholesterols and free fatty acids. Certain catechins existed in the plasma at 0.24 microM under our experimental conditions, though most of them existed as conjugated forms. For mechanisms of the anti-obesity actions, green tea significantly reduced glucose uptake accompanied by a decrease in translocation of glucose transporter 4 (GLUT4) in adipose tissue, while it significantly stimulated the glucose uptake with GLUT4 translocation in skeletal muscle. Moreover, green tea suppressed the expression of peroxisome proliferator-activated receptor gamma and the activation of sterol regulatory element binding protein-1 in adipose tissue. In conclusion, green tea modulates the glucose uptake system in adipose tissue and skeletal muscle and suppresses the expression and/or activation of adipogenesis-related transcription factors, as the possible mechanisms of its anti-obesity actions.


Subject(s)
Adipose Tissue/drug effects , Anti-Obesity Agents/pharmacology , Glucose/metabolism , Plant Extracts/pharmacology , Tea , Transcription Factors/drug effects , Adipose Tissue/anatomy & histology , Animals , Biological Transport/drug effects , Body Weight/drug effects , Leptin/blood , Lipids/blood , Male , Organ Size/drug effects , Phytotherapy , Rats , Rats, Wistar , Transcription Factors/antagonists & inhibitors
20.
Plant Mol Biol ; 48(3): 299-308, 2002 Feb 01.
Article in English | MEDLINE | ID: mdl-11855731

ABSTRACT

Calystegines are nortropane alkaloids that are found in Solanaceae containing the classical tropane alkaloids hyoscyamine and scopolamine, and in other Solanaceae such as potato, Solanum tuberosum (L.). Calystegines are assumed to derive from the classical tropane alkaloid pathway. We isolated a cDNA from S. tuberosum with high homology to the pseudotropine-forming tropinone reductase (TRII), which presents as the first putative metabolite specific to calystegines. The equivalent amino acid sequence shows typical motifs of a short-chain dehydrogenase (SDR). The recombinant TRII protein expressed in Escherichia coli catalyzes pseudotropine formation from tropinone with a Km value, a pH optimum, substrate and co-substrate preferences similar to those reported for the TRII enzymes from other Solanaceae species. The gene is expressed in roots, tubers and aerial parts of potato. The distribution of the TRII transcript in comparison with the calystegine concentrations in the tissues suggests transport of calystegines or their precursors between potato organs.


Subject(s)
Alcohol Oxidoreductases/genetics , Solanum tuberosum/genetics , Amino Acid Sequence , Cloning, Molecular , DNA, Complementary/chemistry , DNA, Complementary/genetics , DNA, Plant/genetics , Escherichia coli/genetics , Gene Expression Regulation, Enzymologic , Gene Expression Regulation, Plant , Molecular Sequence Data , RNA, Messenger/genetics , RNA, Messenger/metabolism , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Sequence Alignment , Sequence Analysis, DNA , Sequence Homology, Amino Acid , Solanum tuberosum/enzymology
SELECTION OF CITATIONS
SEARCH DETAIL